The global genomics market is estimated to reach $23bn by 2022. In 2017, the diagnostic test segment held 27% of the global genomics market. The global genomics market is estimated to grow at a CAGR of 11% throughout the forecast period.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 211-page report you will receive 189 charts– all unavailable elsewhere.
The 211-page report provides clear detailed insight into the genomics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Genomics Market from 2018-2028
• Forecast of the Global Genomics market by Technology: • Sequencing • Microarray • PCR • Nucleic Acid Extraction and Purification • Others
• Forecast of the Global Genomics market by Test Type: • Diagnostic Test • Genetic Test • Newborn Screening • Preimplantation Testing • Prenatal Testing • Carrier Testing
• Forecast of the Global Genomics market by Method: • Molecular Test • Chromosomal Test • Biochemical Test
• Forecast of the Global Genomics market by Application: • Diagnostic • Drug Discovery • Precision Medicine • Others
• Forecast of the Global Genomics market by End-user: • Research Centers • Hospitals and Clinics • Pharmaceutical Companies
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • North America: US, Canada, Rest of North America • Europe: Germany, France, UK, Rest of Europe • Asia-Pacific: China, Japan, India, Rest of Asia-Pacific • Latin America: Mexico, Brazil, Rest of Latin America • Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa
Each regional market is further segmented by technology, test-type, method, application and end-user.
• Our study discusses the selected leading companies that are the major players in the genomics market: • Agilent Technologies, Inc. • Danaher Corporation • Eppendorf AG • BGI Genomics Co. Ltd. • Eurofins Scientific • GE Healthcare Life Sciences • Illumina, Inc. • Oxford Nanopore Technologies Ltd. • Qiagen NV • Roche • Thermo Fisher Scientific, Inc.
• Research interview with a start-up company in the genomic market.
• This report provides the following qualitative analysis of the genomics market: • Market Drivers • Value Chain Analysis of the genomics market • Porter’s Five Forces Analysis of the genomics market • Market Attractiveness Analysis in North America, Europe, Asia-Pacific, Latin America, Middle East & Africa of the genomics market by technology, test-type, method, application and end-user.
Visiongain’s study is intended for anyone requiring commercial analyses for the genomics market. You find data, trends and predictions.
Buy our report today Global Genomics Market Report 2018-2028: Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening, Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test, Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals and Clinics, Pharmaceutical Companies and Others.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Research Scope 1.2 Why You Should Read This Report 1.3 Key Questions Answered by This Analytical Report 1.4 Who is This Report For? 1.5 Methodology 1.6 Frequently Asked Questions (FAQ) 1.7 Associated Visiongain Reports 1.8 About Visiongain
2. Introduction to the Genomics Market 2.1 What is Genomics? 2.2 Classification of Genomics Market 2.3 Market Snapshot: Genomics Market (2017 and 2028) 2.4 Genomics Market Forecast 2016-2028
3. Global Genomics Market Dynamics 3.1 Genomics Market: Drivers 3.1.1 Increase in Private and Public Sector Funding 3.2 Value Chain Analysis of the Genomics Market (Genome Sequencing) 3.3 Porter’s Five Forces Analysis of the Genomics Market. 3.4 Threat of New Entrants [Moderate] 3.5 Power of Suppliers [High] 3.6 Power of Buyers [Low] 3.7 Threat of Substitutes [Low] 3.8 Rivalry among Competitors [High]
4. Global Genomics Submarkets 4.1 Global Genomics Market by Technology, 2017 4.2 Global Genomics Market by Test Type, 2017 4.3 Global Genomics Market by Method, 2017 4.4 Global Genomics Market by Application, 2017 4.5 Global Genomics Market by End-user, 2017 4.6 Global Genomics Market by Geography, 2017
5. Global Genomics Market by Technology: Forecast 2018 – 2028 5.1 Global Genomics Market by Technology: 2018 Vs 2028 (Value %) 5.2 Global Genomics Market by Technology: Forecasts 2018 – 2028
6. Global Genomics Market by Test Type: Forecast 2018 - 2028 6.1 Global Genomics Market by Test Type: 2018 Vs 2028 (Value %) 6.2 Global Genomics Market by Test Type: Forecasts 2018 – 2028
7. Global Genomics Market by Method: Forecasts 2018 - 2028 7.1 Global Genomics Market by Method: 2018 Vs 2028 (Value %) 7.2 Global Genomics Market by Method: Forecasts 2018 – 2028 8. Global Genomics Market by Application: Forecasts 2018 - 2028 8.1 Global Genomics Market by Application: 2018 Vs 2028 (Value %) 8.2 Global Genomics Market Forecast by Application, 2018-2028
9. Global Genomics Market by End-User: Forecasts 2018 – 2028 9.1 Global Genomics Market by End-User: 2018 Vs 2028 (Value %) 9.2 Global Genomics Market Forecast by End-User, 2018-2028
10. Global Genomics Market by Region: Forecasts 2018-2028 10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %) 10.2 Global Genomics Market by Region: Forecasts 2018-2028
11. North America Genomics Market Analysis and Forecasts, 2018 - 2028 11.1 North America Genomics Market Outlook 11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028 11.3 North America Genomics Market by Test Type: Forecasts 2018 – 2028 11.4 North America Genomics Market by Method: Forecasts 2018-2028 11.5 North America Genomics Market by Application: Forecasts 2018-2028 11.6 North America Genomics Market by End-user: Forecasts 2018-2028 11.7 North America Genomics Market by Country: Forecasts 2018 - 2028
12. Europe Genomics Market Analysis and Forecasts, 2018 - 2028 12.1 Europe Genomics Market Outlook 12.2 Europe Genomics Market by Technology: Forecasts 2018 – 2028 12.3 Europe Genomics Market by Test Type: Forecasts 2018-2028 12.4 Europe Genomics Market by Method: Forecasts 2018 – 2028 12.5 Europe Genomics Market by Application: Forecasts 2018-2028 12.6 Europe Genomics Market Analysis by End-user: Forecasts 2018-2028 12.7 Europe Genomics Market Analysis by Country: Forecasts 2018-2028
13. Asia-Pacific Genomics Market Analysis and Forecasts, 2018 - 2028 13.1 Asia-Pacific Genomics Market Outlook 13.2 Asia-Pacific Genomics Market by Technology: Forecasts 2018-2028 13.3 Asia-Pacific Genomics Market by Test Type: Forecasts 2018-2028 13.4 Asia-Pacific Genomics Market by Method: Forecasts 2018-2028 13.5 Asia-Pacific Genomics Market by Application: Forecasts 2018-2028 13.6 Asia-Pacific Genomics Market by End-User: Forecasts 2018-2028 13.7 Asia-Pacific Genomics Market Analysis, 2018 - 2028 by Country 14. Middle East & Africa Genomics Market Analysis and Forecasts, 2018 - 2028 14.1 Middle East & Africa Genomics Market Outlook 14.2 Middle East & Africa Genomics Market by Technology: Forecasts 2018 – 2028 14.3 Middle East & Africa Genomics Market by Test Type: Forecasts 2018 – 2028 14.4 Middle East & Africa Genomics Market by Method: Forecasts 2018-2028 14.5 Middle East & Africa Genomics Market by Application: Forecasts 2018-2028 14.6 Middle East & Africa Genomics Market by End-User: Forecasts 2018-2028 14.7 Middle East & Africa Genomics Market Analysis, 2018 - 2028 by Country
15. Latin America Genomics Market Analysis and Forecasts 2018 - 2028 15.1 Latin America Genomics Market Outlook 15.2 Latin America Genomics Market by Technology: Forecasts 2018 – 2028 15.3 Latin America Genomics Market by Test Type: Forecasts 2018-2028 15.4 Latin America Genomics Market by Method: Forecasts 2018-2028 15.5 Latin America Genomics Market Analysis by Application: Forecasts 2018-2028 15.6 Latin America Genomics Market by End-User: Forecasts 2018-2028 15.7 Latin America Genomics Market by Country: Forecasts 2018-2028
16. Leading Companies in the Genomics Market 16.1 Illumina Inc. 16.1.1 Illumina Inc. Geographical Presence 16.1.2 Illumina Historic Roadmap 16.1.3 Illumina, Inc. Recent Developments 16.1.4 Illumina Inc, Product Portfolio 16.1.5 Illumina Inc., Sales Analysis 16.2 Agilent Technologies, Inc. 16.2.1 Agilent Technologies, Inc. Geographical Presence 16.2.2 Agilent Technologies, Inc. Recent Developments 16.2.3 Agilent Technologies, Inc. Product Portfolio 16.2.4 Agilent Technologies, Inc. Sales Analysis 16.3 Thermo Fisher Scientific, Inc. 16.3.1 Thermo Fisher Scientific, Inc. Geographical Presence 16.3.2 Thermo Fisher Scientific, Inc. Recent Developments 16.3.3 Thermo Fisher Scientific, Inc. Product Portfolio 16.3.4 Thermo Fisher Scientific, Inc. Sales Analysis 16.4 Eurofins Scientific 16.4.1 Eurofins Scientific Geographical Presence 16.4.2 Eurofins Scientific Recent Developments 16.4.3 Eurofins Scientific Product Portfolio 16.4.4 Eurofins Scientific Sales Analysis 16.5 QIAGEN NV 16.5.1 QIAGEN NV: Geographical Presence 16.5.2 QIAGEN NV Recent Developments 16.5.3 QIAGEN NV Product Portfolio 16.5.4 QIAGEN NV: Sales Analysis 16.6 GE Healthcare Life Sciences 16.6.1 GE Healthcare Life Sciences Geographical Presence 16.6.2 GE Healthcare Life Sciences Product Portfolio 16.6.3 GE Healthcare Life Sciences Sales Analysis 16.7 Eppendorf AG 16.7.1 Eppendorf AG Geographical Presence 16.7.2 Eppendorf AG Product Portfolio 16.7.3 Eppendorf AG Sales Analysis 16.8 Danaher Corporation 16.8.1 Danaher Corporation Geographical Presence 16.8.2 Danaher Corporation Product Portfolio 16.8.3 Danaher Corporation: Sales Analysis 16.9 BGI Genomics Co. Ltd. 16.9.1 BGI Genomics Co. Ltd. Geographical Presence 16.9.2 BGI Genomics Co. Ltd. Product Portfolio 16.9.3 BGI Genomics Co. Ltd. Sales Analysis 16.10 Oxford Nanopore Technologies Ltd. 16.10.1 Oxford Nanopore Technologies Ltd. Product Portfolio 16.11 F. Hoffmann-La Roche Ltd 16.11.1 F. Hoffmann-La Roche Ltd Geographical Presence 16.11.2 F. Hoffmann-La Roche Ltd Product Portfolio 16.11.3 F. Hoffmann-La Roche Ltd: Sales Analysis 16.12 SeqOne S.A.S 16.12.1 SeqOne S.A.S Product Portfolio 16.13 Other Active Companies in the Genomics Market
17. Research Interview 17.1 Interview with Jean-Marc Holder, CCO, SeqOne 17.2 Drivers of the Genomics Market 17.3 Challenges Faced by the Genomics Industry 17.4 SeqOne: Vision and Mission 17.5 French Genomics Market 17.6 Trends in the Genomics Market 17.7 SeqOne: Ambition and Strategies
18. Conclusions
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form
List of Tables Table 2.1 Market Snapshot: Genomics Market (2017 and 2028) Table 2.2 Genomics Market Forecast 2017 – 2028: Revenue ($bn) and AGR (%) Table 5.1 Global Genomics Market Forecast by Technology: Revenue ($bn), AGR (%), CAGR (%), 2017 – 2028 Table 6.1 Global Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2017 – 2028 Table 7.1 Global Genomics Market by Method: Revenue 9$bn), AGR (%), CAGR (%), 2018-2028 Table 8.1 Global Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 9.1 Global Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 10.1 Global Genomics Market by Region: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 11.1 North America Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 11.2 North America Genomics Market by Application: Revenue ($bn). AGR (%), CAGR (%), 2018-2028 Table 11.3 North America Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 11.4 North America Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 11.5 North America Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 11.6 North America Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 12.1 Europe Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 12.2 Europe Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 12.3 Europe Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 12.4 Europe Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 12.5 Europe Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 12.6 Europe Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 13.1 Asia-Pacific Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 13.2 Asia-Pacific Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 13.3 Asia-Pacific Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 13.4 Asia-Pacific Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 13.5 Asia-Pacific Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 13.6 Asia-Pacific Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 14.1 Middle East & Africa Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 14.2 Middle East & Africa Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 14.3 Middle East & Africa Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 14.4 Middle East & Africa Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 14.5 Middle East & Africa Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 14.6 Middle East & Africa Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 15.1 Latin America Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 15.2 Latin America Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 15.3 Latin America Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Table 15.4 Latin America Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 15.5 Latin America Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 15.6 Latin America Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028 Table 16.1 IIlumina Inc, Product Portfolio Table 16.2 Agilent Technolgies, Inc. Product Portfolio Table 16.3 Agilent Technolgies, Inc. Genomics Product Portfolio Table 16.4 Thermo Fisher Scientific, Inc. Product Portfolio Table 16.5 Thermo Fisher Scientific, Inc. Genomics Product Portfolio Table 16.6 Eurofins Scientific Product Portfolio Table 16.7 Eurofins Scientific Genomics Product Portfolio Table 16.8 QIAGEN NV: Product Portfolio Table 16.9 GE Healthcare Life Sciences: Product Portfolio Table 16.10 GE Healthcare Life Sciences Genomics: Product Portfolio Table 16.11 Eppendorf AG: Product Portfolio Table 16.12 Danaher Corporation: Product Portfolio Table 16.13 BGI Genomics Co. Ltd.: Product Portfolio Table 16.14 BGI Genomics Co. Ltd. Genomics: Product Portfolio Table 16.15 Oxford Nanopore Technologies Ltd.: Product Portfolio Table 16.16 Oxford Nanopore Technologies Ltd.: Genomics Product Portfolio Table 16.17 F. Hoffmann-La Roche Ltd: Product Portfolio Table 16.18 SeqOne S.A.S Product Portfolio Table 16.19 SeqOne S.A.S Genomics Product (SeqOne Platform) Table 16.20 Other Companies in the Genomics Industry
List of Figures Figure 1.1 Global Genomics Market Segmentation Overview, 2017 Figure 2.1 Global Genomics Market. Segmentation Overview Figure 2.2 Genomics Market Forecast 2017 – 2028: Revenue ($bn) and AGR (%) Figure 3.1 Value Chain Analysis of the Genomics Market Figure 4.1 Global Genomics Market, by Technology, 2017 (%) Figure 4.2 Global Genomics Market by Test Type, 2017 (%) Figure 4.3 Global Genomics Market by Method, 2017 (%) Figure 4.4 Global Genomics Market by Application, 2017 (%) Figure 4.5 Global Genomics Market by End-user, 2017 (%) Figure 4.6 Global Genomics Market by Geography, 2017 (%) Figure 5.1 Global Genomics Market by Technology: Market Share 2018 Vs 2028 (Value %) Figure 5.2 Global Genomics Market Forecast by Technology: Revenue ($bn), 2018 – 2028 Figure 6.1 Global Genomics Market by Test Type: Market Share 2018 Vs 2028 (Value %) Figure 6.2 Global Genomics Market by Test Type: Revenue ($bn), 2018 – 2028 Figure 7.1 Global Genomics Market by Method Market Share, 2018 Vs 2028 (Value %) Figure 7.2 Global Genomics Market by Method: Revenue ($bn), 2018 – 2028 Figure 8.1 Global Genomics Market by Application: 2018 Vs 2028 (Value %) Figure 8.2 Global Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028 Figure 9.1 Global Genomics Market by End-User – 2018 Vs 2028 (Value %) Figure 9.2 Global Genomics Market by End-User: Revenue ($bn), 2018 – 2028 Figure 10.1 Global Genomics Market Share by Geography: 2018 and 2028 (%) Figure 10.2 Global Genomics Market by Region: 2018, (% Share) Figure 10.3 Global Genomics Market by Region: Revenue ($bn), 2018-2028 Figure 11.1 North America Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028 Figure 11.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%) Figure 11.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%) Figure 11.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%) Figure 11.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%) Figure 11.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%) Figure 11.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%) Figure 11.8 North America Genomics Market by Technology: Revenue ($bn) Figure 11.9 North America Genomics Market by Test Type: Revenue ($bn), 2018-2028 Figure 11.10 North America Genomics Market by Method: Revenue ($bn), 2018-2028 Figure 11.11 North America Genomics Market by Application: Forecasts 2018-2028 Figure 11.12 North America Genomics Market by End-user: Revenue ($bn), 2018-2028 Figure 11.13 North America Genomics Market by Country: Revenue ($bn), 2018-2028 Figure 12.1 Europe Genomics Market Outlook: Revenue ($bn), 2018. 2021, 2024, 2028 Figure 12.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%) Figure 12.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%) Figure 12.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%) Figure 12.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%) Figure 12.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%) Figure 12.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%) Figure 12.8 Europe Genomics Market by Technology: Revenue ($bn), 2018-2028 Figure 12.9 Europe Genomics Market by Test Type: Revenue ($bn), 2018-2028 Figure 12.10 Europe Genomics Market by Method: Revenue ($bn), 2018-2028 Figure 12.11 Europe Genomics Market by Application: Revenue ($bn), 2018-2028 Figure 12.12 Europe Genomics Market by End-user: Revenue ($bn), 2018-2028 Figure 12.13 Europe Genomics Market by Country: Revenue ($bn), 2018-2028 Figure 13.1 Asia-Pacific Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028 Figure 13.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%) Figure 13.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%) Figure 13.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%) Figure 13.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%) Figure 13.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%) Figure 13.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%) Figure 13.8 Asia-Pacific Genomics Market by Technology: Revenue ($bn), 2018-2028 Figure 13.9 Asia-Pacific Genomics Market by Test Type: Revenue ($bn), 2018-2028 Figure 13.10 Asia-Pacific Genomics Market by Method: Revenue ($bn), 2018-2028 Figure 13.11 Asia-Pacific Genomics Market by Application: Revenue ($bn), 2018-2028 Figure 13.12 Asia-Pacific Genomics Market by End-User: Revenue ($bn), 2018-2028 Figure 13.13 Asia-Pacific Genomics Market by Country: Revenue ($bn), 2018-2028 Figure 14.1 Middle East & AfricaGenomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028 Figure 14.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%) Figure 14.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%) Figure 14.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%) Figure 14.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%) Figure 14.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%) Figure 14.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%) Figure 14.8 Genomics Market by Technology: Revenue ($bn), 2018-2028 Figure 14.9 Middle East & Africa Genomics Market by Test Type: Revenue ($bn), 2018-2028 Figure 14.10 Middle East & Africa Genomics Market by Method: Revenue ($bn), 2018-2028 Figure 14.11 Middle East & Africa Genomics Market by Application: Revenue ($bn), 2018-2028 Figure 14.12 Middle East & Africa Genomics Market by End-User: Revenue ($bn), 2018-2028 Figure 14.13 Middle East & Africa Genomics Market by Country: Revenue ($bn), 2018-2028 Figure 15.1 Latin America Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028 Figure 15.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%) Figure 15.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%) Figure 15.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%) Figure 15.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%) Figure 15.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%) Figure 15.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%) Figure 15.8 Latin America Genomics Market by Technology: Revenue ($bn), 2018-2028 Figure 15.9 Latin America Genomics Market by Test Type: Revenue ($bn), 2018-2028 Figure 15.10 Latin America Genomics Market by Method: Revenue ($bn), 2018-2028 Figure 15.11 Latin America Genomics Market by Application: Revenue ($bn), 2018-2028 Figure 15.12 Latin America Genomics Market. Analysis by End-User: Revenue ($bn), 2018-2028 Figure 15.13 Latin America Genomics Market. Analysis, 2018 - 2028 by Country Figure 16.1 Leading Companies, Genomics Market Share, 2017 (% share) Figure 16.2 Illumina Inc: Sales Analysis by Business Segments ($m) 2015 - 2017 Figure 16.3 Illumina Inc.: Sales Analysis by Business Segments (% Share), 2017 Figure 16.4 Illumina Inc.: Sales Analysis by Geographic Segments ($m), 2015 - 2017 Figure 16.5 Agilent Technologies, Inc: Sales Analysis ($m), 2015 - 2017 Figure 16.6 Agilent Technologies, Inc.: Sales Analysis by Business Segments (% Share), 2017 Figure 16.7 Agilent Technologies: Inc. Sales Analysis by Product Segments (% Share), 2017 Figure 16.8 Agilent Technologies, Inc.: Sales Analysis by Product Segments ($m), 2015 - 2017 Figure 16.9 Agilent Techologies, Inc.: Sales Analysis by Geography (% Share), 2017 Figure 16.10 Thermo Fisher Scientific, Inc.: Sales Analysis ($m), 2015 - 2017 Figure 16.11 Thermo Fisher Scientific, Inc.: Sales Analysis by Business Segments (% Share), 2017 Figure 16.12 Thermo Fisher Scientific, Inc.: Sales Analysis by Product Segments (% Share), 2017 Figure 16.13 Thermo Fisher Scientific, Inc.: Sales Analysis by Product Segments ($m), 2015 - 2017 Figure 16.14 Thermo Fisher Scientific, Inc.: Sales Analysis by Geography (% Share), 2017 Figure 16.15 Eurofins Scientific Sales Analysis (€m), 2015 - 2017 Figure 16.16 Eurofins Scientific Sales Analysis by Geography (% Share), 2017 Figure 16.17 Eurofins Scientific: Sales Analysis by Geography (€m), 2015-2017 Figure 16.18 QIAGEN NV: Sales Analysis ($m), 2015 - 2017 Figure 16.19 QIAGEN NV: Sales Analysis by Business Segments (% Share), 2017 Figure 16.20 QIAGEN NV: Sales Analysis by Geography ($m), 2015 - 2017 Figure 16.21 QIAGEN NV: Sales Analysis by Geography (% Share), 2017 Figure 16.22 GE Healthcare Life Sciences: Sales Analysis ($m), 2015 - 2017 Figure 16.23 GE Healthcare Life Sciences: Sales Analysis by Business Segments (% Share), 2017 Figure 16.24 GE Healthcare Life Sciences: Sales Analysis by Product Segments (% Share), 2017 Figure 16.25 GE Healthcare Life Sciences: Sales Analysis by Geography (% Share), 2017 Figure 16.26 GE Healthcare Life Sciences: Sales Analysis by Geography ($m), 2015 - 2017 Figure 16.27 Eppendorf AG: Sales Analysis (€m), 2015 - 2017 Figure 16.28 Eppendorf AG: Sales Analysis by Geography (% Share), 2017 Figure 16.29 Eppendorf AG: Sales Analysis by Geography (€m), 2015 - 2017 Figure 16.30 Danaher Corporation: Sales Analysis ($m), 2015 - 2017 Figure 16.31 Danaher Corporation: Sales Analysis by Business Segments (% Share), 2017 Figure 16.32 Danaher Corporation: Sales Analysis by Product Segments ($m), 2015 - 2017 Figure 16.33 Danaher Corporation Sales Analysis by Geography (%Share), 2017 Figure 16.34 BGI Genomics Co. Ltd.: Sales Analysis (Mn CNY), 2015 - 2017 Figure 16.35 BGI Genomics Co. Ltd.: Sales Analysis by Business Segments (% Share), 2017 Figure 16.36 BGI Genomics Co. Ltd.: Sales Analysis by Product Segments (Mn CNY), 2015 - 2017 Figure 16.37 BGI Genomics Co. Ltd.: Sales Analysis by Geography (% Share), 2017 Figure 16.38 BGI Genomics Co. Ltd.: Sales Analysis by Geography (Mn CNY), 2015 - 2017 Figure 16.39 F. Hoffmann-La Roche Ltd: Sales Analysis (CHF Mn), 2015 - 2017 Figure 16.40 F. Hoffmann-La Roche Ltd: Sales Analysis by Business Segments (% Share), 2017 Figure 16.41 F. Hoffmann-La Roche Ltd: Sales Analysis by Product Segments (CHF Mn), 2015 - 2017 Figure 16.42 F. Hoffmann-La Roche Ltd: Sales Analysis by Geography (% Share), 2017 Figure 16.43 F. Hoffmann-La Roche Ltd: Sales Analysis by Geography (CHF Mn), 2015 - 2017
10x Genomics 23andMe, Inc. Affymetrix Agilent Technologies, Inc. Ancestry Annoroad BGI Bio-Rad Laboratories Bristol-Myers Squibb CENTOGENE AG Clinical Genomics Technologies Pty Ltd. Color Genomics Core Informatics Counsyl CRISPR Therapeutics Cura Integrative Medicine Danaher DeCODE Deep Genomics Edico Genome Editas Medicine Epicentre Biotechnologies Eppendorf Eurofins Scientific F. Hoffmann-La Roche Foundation Medicine, Inc. Futura Genetics GATC Biotech GE Healthcare Gene by Gene Ltd Genohm GenomeDx Biosciences, Inc. Genomic Health, Inc. Genomics England Genomix Nutrition, Inc. IBM Watson for Genomics Illumina Inivata Intellia Therapeutics Invitae Corporation Iverson Genetic Diagnostics, Inc. Life Technologies Loxo Oncology MedGenome Metagenics, Inc MyDNA Myriad Genetics, Inc. Natera, Inc. National Geographic’s ancestry test NeoGenomics, Inc. NutraGene Nutrigenomix OPKO Health, Inc. Oxford Nanopore Technologies Ltd. PacBio Pacific Biosciences of California Pathgroup PerkinElmer, Inc. Personalis, Inc. PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH Qiagen Quest Diagnostics Incorporated Retrogen, Inc. Roche Rosetta Genomics, Ltd. Sentieon Solexa, Inc. Strand Life Sciences Pvt. Ltd. Thermo Fisher Scientific Verge Genomics Verily Life Sciences Veritas Genetics WellGen Inc. WuXi NextCODE XCODE Life Sciences Pvt. Ltd.
List of Organizations Mentioned in the Report Emory Genetics Laboratory (EGL) Emory University's School of Medicine National Institutes of Health (NIH) Organization for Economic Cooperation and Development (OECD) South African Medical Research Council (SAMRC) The Brazilian Society of Medical Genetics [Sociedade Brasileira de Genética Médica (SBGM) University of Leuven
Download sample pages
Complete the form below to download your free sample pages for Global Genomics Market Report 2018-2028
The Alzheimer’s Disease Therapeutics and Diagnostics Market will reach $7.93bn in 2018. The Alzheimer’s Disease Therapeutics and Diagnostics Market is...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
